Prospect Capital Corp(PBC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PBC Prospect Capital Corp

退市 05-08 14:33:40 EDT

25.06

+0.00

0.00%

最高25.06	最低25.06	成交量0.00
今开25.06	昨收25.06	日振幅0.00%
总市值92.18亿	流通市值0.00	总股本3.68亿
成交额31.97万	换手率--	流通股本0.00
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PBC","market":"US","secType":"STK","nameCN":"Prospect Capital Corp","latestPrice":25.06,"timestamp":1640811600000,"preClose":25.06,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":367817926,"eps":0.367626,"marketStatus":"退市","change":0,"latestTime":"05-08 14:33:40 EDT","open":25.06,"high":25.06,"low":25.06,"amount":319705.1613,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.367626,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1778270400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":25.06,"dividendRate":0.028731,"volumeRatio":0},"requestUrl":"/m/hq/s/PBC","defaultTab":"news","newsList":[{"id":"2633482458","title":"Anthropic更上一层楼！传今夏拟筹资500亿美元 估值逼近万亿美元反超OpenAI","url":"https://stock-news.laohu8.com/highlight/detail?id=2633482458","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633482458?lang=zh_cn&edition=full","pubTime":"2026-05-08 14:46","pubTimestamp":1778222785,"startTime":"0","endTime":"0","summary":"据报道，Anthropic正考虑于今夏筹集数百亿美元，以大幅扩展计算能力，届时其估值将接近1万亿美元，超越OpenAI——该公司在今年3月刚以8520亿美元估值完成创纪录的1220亿美元融资。三位知情人士称，Anthropic有望通过本轮融资筹集高达500亿美元的资金。2026年初企业支出数据显示，在首次采购AI工具的企业中，Anthropic已占据73%的份额，市场份额反超OpenAI。作为Anthropic的主要竞争对手，OpenAI同样计划在2026年下半年启动IPO。其次，Anthropic独特的治理结构可能引发投资者担忧。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BKPKM429.USD","IE00B19Z9505.USD","NVDA","AGIX","LU0276348264.USD","IE00B19Z8W00.USD","MSFT","LU2237443549.SGD","ARTY","PBC","SPCX","USAW.SI","LU1880398554.USD","LU0061474960.USD","CHAT","LU0683600562.USD","LU0861579265.USD","LU2028103732.USD","BK4122","IPO","YMAG","AMZN","LU0323591593.USD","LU1267930730.SGD","USJW.SI","AMZD","AMZZ","LU2237443978.SGD","GOOG","WTAI","SG9999015945.SGD","IPOS","AMZW","LU1989764748.USD","AMZY","LU2420271590.USD","LU1880398471.USD","META","LU2462591350.SGD","TSLA","AMZU","AMZP","ARR","AAPL","BULZ","AZYY","LU0133085943.USD","LU0345768740.USD","IE0034235303.USD","MAGY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620022594","title":"OpenAI冲刺年底IPO：砍掉支线业务全力为企业变现，2030年收入剑指2800亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620022594","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620022594?lang=zh_cn&edition=full","pubTime":"2026-03-18 08:45","pubTimestamp":1773794730,"startTime":"0","endTime":"0","summary":"知情人士透露，OpenAI首次公开募股最快或于今年年底前启动，但具体时间仍存调整可能。据此前报道，OpenAI首席执行官萨姆·奥尔特曼曾大力宣扬的1.4万亿美元投资目标，已在2月份向投资者沟通时调整为——到2030年实现约6000亿美元的总计算支出规模。OpenAI最新预测显示，2030年总收入将突破2800亿美元，其中消费者业务与企业业务的贡献占比将基本持平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PBC","IPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611116168","title":"Tharimmune, Inc.盘中异动 早盘急速拉升5.14%报4.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611116168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611116168?lang=zh_cn&edition=full","pubTime":"2026-02-14 00:15","pubTimestamp":1770999328,"startTime":"0","endTime":"0","summary":"北京时间2026年02月14日00时15分，Tharimmune, Inc.股票出现波动，股价快速上涨5.14%。截至发稿，该股报4.50美元/股，成交量11.1782万股，换手率0.28%，振幅6.54%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为2.04%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021400152897a62334&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021400152897a62334&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","CNTN","BK4139","PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593246855","title":"吉利德：原发性胆汁性胆管炎药物Seladelpar在海南博鳌乐城获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2593246855","media":"人民财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593246855?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:45","pubTimestamp":1766457935,"startTime":"0","endTime":"0","summary":"【吉利德：原发性胆汁性胆管炎药物Seladelpar在海南博鳌乐城获批】12月22日，吉利德原发性胆汁性胆管炎(PBC)药物Seladelpar在海南博鳌乐城国际医疗旅游先行区获批，适用于与熊去氧胆酸（UDCA）联合治疗对UDCA单药应答不佳的PBC成人患者，或作为单药用于治疗无法耐受UDCA的PBC成人患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202512233599290123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593430618","title":"Tharimmune, Inc.盘中异动 早盘股价大涨9.48%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593430618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593430618?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:31","pubTimestamp":1766413907,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日22时31分，Tharimmune, Inc.股票出现波动，股价快速拉升9.48%。截至发稿，该股报2.54美元/股，成交量21.4924万股，换手率0.61%，振幅2.15%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223147a46ae19c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223147a46ae19c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","PBC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582373562","title":"Tharimmune, Inc.盘中异动 临近午盘股价大跌6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582373562?lang=zh_cn&edition=full","pubTime":"2025-11-12 00:30","pubTimestamp":1762878642,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日00时30分，Tharimmune, Inc.股票出现异动，股价快速下挫6.46%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112003042a49a46ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112003042a49a46ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516670075","title":"Tharimmune, Inc.盘中异动 大幅下挫6.21%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670075?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098734,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Tharimmune, Inc.股票出现异动，股价快速下挫6.21%。截至发稿，该股报1.36美元/股，成交量56.5869万股，换手率29.26%，振幅0.69%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214a25f049a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214a25f049a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514686977","title":"Tharimmune, Inc.盘中异动 下午盘快速上涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514686977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514686977?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:02","pubTimestamp":1740596538,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时02分，Tharimmune, Inc.股票出现异动，股价大幅上涨5.67%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6518.56%、288.25%、256.53%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Organovo Holdings, Inc.，振幅分别为194.07%、81.11%、52.76%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270302189631805d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270302189631805d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512662459","title":"外媒：OpenAI辉煌时代已经结束","url":"https://stock-news.laohu8.com/highlight/detail?id=2512662459","media":"鞭牛士Bianews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512662459?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:00","pubTimestamp":1739977239,"startTime":"0","endTime":"0","summary":"鞭牛士报道，2月19日消息，ITPro分析认为，OpenAI 的辉煌时代已经结束。OpenAI 曾经表现良好，但我认为，它备受关注的时代即将结束。目前尚不清楚此次重组将如何影响 OpenAI 的长期财务困境，但目前该公司的状况大致相同。例如，本月早些时候，竞争对手人工智能公司 Figure 宣布将终止与 OpenAI 的交易。这还有待观察，但很明显，OpenAI 不再是曾经的领跑者。DeepSeek 是该领域的新秀，它是一种全新的替代方案，让 OpenAI 看起来几乎过时了。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8h6rHRpjp8N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["LU0056508442.USD","LU1236620834.HKD","LU1244550221.USD","LU2023250504.SGD","LU0302445910.USD","LU2023250330.USD","LU2041044095.USD","LU0795875169.SGD","IE00BJJMRY28.SGD","LU0170899867.USD","LU0080751232.USD","LU2360108059.USD","LU1267930730.SGD","LU1861127337.USD","LU0149725797.USD","IE0003U64NQ7.SGD","LU0347712357.USD","LU1791710400.SGD","LU2505996509.AUD","LU1043141396.HKD","LU0894486033.HKD","LU0251132253.USD","SG9999015341.SGD","LU2242650005.HKD","LU0444971666.USD","LU0316494557.USD","BK4538","LU1564329461.SGD","LU0310800379.SGD","LU0097036916.USD","MSFT","LU0053666078.USD","LU1116320901.HKD","LU0784385840.USD","BK4535","LU2360032135.SGD","IE0004445239.USD","LU2213496289.HKD","BK4532","SG9999014898.SGD","PBC","IE00B19Z8W00.USD","LU2092937221.SGD","LU2092627202.USD","LU2471134796.USD","LU2237443978.SGD","IE00BN8TJ469.HKD","LU0203202063.USD","LU1914381329.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2506889898","title":"Tharimmune, Inc.盘中异动 股价大跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506889898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506889898?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:24","pubTimestamp":1737735891,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时24分，Tharimmune, Inc.股票出现异动，股价快速下挫6.02%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Evaxion Biotech As、Neuphoria Therapeutics Inc.、Pmgc Holdings Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为3872.49%、2103.81%、1560.72%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Neuphoria Therapeutics Inc.，振幅分别为134.08%、112.09%、107.98%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125002451abb76906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125002451abb76906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","PBC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505271269","title":"【美股太空概念股强势上涨 Rocket Lab涨超15%】美股太空概念股强势上涨，Redwire涨超18%，卫讯公司、Planet Labs PBC涨超17%，Rocket Lab涨超15%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505271269","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505271269?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:41","pubTimestamp":1737470486,"startTime":"0","endTime":"0","summary":"美股太空概念股强势上涨，Redwire涨超18%，卫讯公司、Planet Labs PBC涨超17%，Rocket Lab涨超15%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1c8a81e67451b11a95c6db39ac88b8b4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/21224147677448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VSAT","PBC","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502564680","title":"大模型不再有信仰","url":"https://stock-news.laohu8.com/highlight/detail?id=2502564680","media":"三言财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502564680?lang=zh_cn&edition=full","pubTime":"2025-01-08 23:31","pubTimestamp":1736350303,"startTime":"0","endTime":"0","summary":"AI大模型的“AGI信仰”可能正处在崩溃边缘，与曾经的“区块链信仰”殊途同归。2025年，可能是AI大模型“信仰崩塌”元年。除了OpenAI，国内外其他大模型公司或多或少也都出现不同问题。2024年10月，AI大模型公司波形智能解散，多名团队核心成员入职OPPO。还有像Adept、Reka AI、Humane等大模型公司均遭遇不同程度的运营危机，已被收购或者正寻求出售。2025年各大模型公司应该会更加务实，还是那句话，只有活得下去才有实现目标的可能，“信仰”不再重要。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8fzFKx2Z2vL","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495663588","title":"AI教父、诺奖得主Hinton支持起诉OpenAI，阻止“转盈利”","url":"https://stock-news.laohu8.com/highlight/detail?id=2495663588","media":"机器之心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495663588?lang=zh_cn&edition=full","pubTime":"2024-12-31 12:23","pubTimestamp":1735619033,"startTime":"0","endTime":"0","summary":"正在与 OpenAI 打官司的首富马斯克此前已在 11 月提起了联邦诉讼，寻求初步禁令以阻止 OpenAI 转型。甚至包括诺贝尔奖得主 Geoffrey Hinton。本周一，青年倡导组织 Encode 提交了一份法庭之友陈述，支持伊隆马斯克正在进行的诉讼，以阻止 OpenAI 的公司转型。OpenAI 于 2015 年作为非营利研究实验室成立。OpenAI 的非营利组织部分将保留，但将放弃控制权以换取 PBC 的股份。Encode 认为，OpenAI 所宣扬的对人类的责任将消失，因为特拉华州法律明确规定，PBC 的董事对公众不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8flCiryqOr6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["LU0498741114.HKD","LU0498741890.SGD","BK4017","LU0055631609.USD","LU0368265764.SGD","AGI","PBC","LU0496367417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494994163","title":"OpenAI营利性公司将转变为特拉华州公共利益公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2494994163","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494994163?lang=zh_cn&edition=full","pubTime":"2024-12-28 15:26","pubTimestamp":1735370789,"startTime":"0","endTime":"0","summary":"当地时间12月27日，OpenAI公司董事会称正在评估公司结构，以便更好地实现通用人工智能造福人类的使命。此前已有市场消息称，OpenAI将把公司核心业务重组为营利性组织，不再受非营利性公司董事会控制。从OpenAI此次释放的消息看，虽然OpenAI并未提及核心业务所在的子公司将不受非营利性公司董事会控制，但子公司和原本的非营利性母公司的业务更加分开了。OpenAI在文章中称，目前公司的结构无法让董事会充分考虑为公司提供资金方的利益。","market":"us","thumbnail":"http://n.sinaimg.cn/default/feedbackpics/transform/116/w550h366/20180409/i7qC-fytnfyp1107515.png","type":0,"news_type":0,"thumbnails":["http://n.sinaimg.cn/default/feedbackpics/transform/116/w550h366/20180409/i7qC-fytnfyp1107515.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-28/doc-ineazawr4704345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["PBC","LU0496367417.USD","LU0498741890.SGD","LU0498741114.HKD","LU0055631609.USD","BK4017","AGI","LU0368265764.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494838367","title":"OpenAI拟改变架构 计划成立更传统营利性公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2494838367","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494838367?lang=zh_cn&edition=full","pubTime":"2024-12-28 12:20","pubTimestamp":1735359600,"startTime":"0","endTime":"0","summary":"OpenAI 的新架构旨在成为一家更加受投资者欢迎的公司，同时保持资助相关慈善事业的使命。OpenAI现有的营利部门目前由其非营利组织控制。OpenAI成立于2015年，最初是一家非营利组织，但为了获得投资，该公司在2019年成立了一家名为营利性子公司。今年年初，OpenAI员工出售现有股份时，该公司的估值为860亿美元。早在8月底传出OpenAI进行新一轮融资的消息时，就有多家媒体爆料称，该公司考虑改变自身架构，从而使其对投资者更具吸引力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1230490.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494548583","title":"华尔街见闻早餐FM-Radio | 2024年12月28日","url":"https://stock-news.laohu8.com/highlight/detail?id=2494548583","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494548583?lang=zh_cn&edition=full","pubTime":"2024-12-28 07:16","pubTimestamp":1735341361,"startTime":"0","endTime":"0","summary":"五分钟看懂全球市场，尽在财经早餐。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/71292bf9-431c-4b21-8530-055bcb9e73a0.jpeg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/71292bf9-431c-4b21-8530-055bcb9e73a0.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3737955","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["SGXZ81514606.USD","LU0868494617.USD","SDS","NVDS.UK","NVDA","LU2125909916.SGD","LU0345768153.USD","LU1861220033.SGD","LU0354030438.USD","NVDX","BK4532","OEX","LU1623119135.USD","SH","UPRO",".SPX","SG9999002232.USD","ESmain","LU0787776722.HKD","LU2264538146.SGD","2NVD.UK","SNVD.UK","SPY","3NVD.UK","NVIW.SI","IE00BJJMRY28.SGD","LU1571399168.USD","IVV","NVD","LU0077335932.USD","NVD2.UK","NVDD","SSO","NVDY","LU1989772923.USD","NVD3.UK","OEF","SPXU","NVDS","LU2326559502.SGD","NVDU","IE00B3M56506.USD","LU1323610961.USD","IE00BDCRKT87.USD","PBC","IE00BD6J9T35.USD","BK4527","LU0094547139.USD","LU2602419157.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2494357330","title":"突发！刚刚，OpenAI裂变成了两块：一块营利，一块非营利","url":"https://stock-news.laohu8.com/highlight/detail?id=2494357330","media":"机器之心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494357330?lang=zh_cn&edition=full","pubTime":"2024-12-28 01:24","pubTimestamp":1735320286,"startTime":"0","endTime":"0","summary":"根据 OpenAI 的最新声明，新一轮组织结构调整是围绕营利与非营利的矛盾展开的。伊隆马斯克甚至与 OpenAI 反目成仇，提起了诉讼。今天起，我们有了一个非营利组织和一个营利组织，我们将继续同时拥有这两个组织。毫无疑问，OpenAI 在这里引入了一个不常见的公司组织架构模式，引发了很多人的困惑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8ffQQjnmw6j","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["LU0496367417.USD","LU0368265764.SGD","AGI","LU0498741890.SGD","LU0498741114.HKD","LU0055631609.USD","PBC","BK4017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494873243","title":"OpenAI公布重组计划：拟转型公益企业 以吸引更多投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2494873243","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494873243?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:51","pubTimestamp":1735314660,"startTime":"0","endTime":"0","summary":"财联社12月27日讯 当地时间周五，人工智能研究公司OpenAI公布了一项重组计划，将采用公益企业模式，此举旨在更好地吸引投资。　　据悉，OpenAI董事会正在评估一项计划，拟将公司现有的营利性业务转变为特拉华州公益企业，公益企业将负责OpenAI的运营和业务。　　OpenAI现有的营利部门目前由其非营利组织控制。OpenAI成立于2015年，最初是一家非营利组织，但为了获得投资，该公司在2019年成立了一家名为营利性子公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-27/doc-ineaxqvr4032770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494384917","title":"Tharimmune, Inc.盘中异动 早盘大幅下挫6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494384917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494384917?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:32","pubTimestamp":1735313558,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时32分，Tharimmune, Inc.股票出现异动，股价大幅下跌6.98%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Galectin Therapeutics Inc.、Abpro Holdings, Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为103.36%、45.37%、20.70%，振幅较大的相关个股有Galectin Therapeutics Inc.、Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为65.39%、62.45%、58.33%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227233238ab94ffbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227233238ab94ffbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prospectstreet.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.1098},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.3037},{"period":"ytd","weight":0.0728}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prospect Capital Corporation成立于2004年4月13日，是一家封闭式投资公司。公司是一家金融服务公司，主要向中等市场的私人控股公司提供贷款和投资。公司是一家在马里兰州注册成立的封闭式投资公司。其投资目标是通过债务和股权投资实现当期收益和长期资本增值。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.034529},{"month":2,"riseRate":0,"avgChangeRate":-0.031267},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.060348},{"month":4,"riseRate":1,"avgChangeRate":0.067548},{"month":5,"riseRate":0.333333,"avgChangeRate":0.002978},{"month":6,"riseRate":0.666667,"avgChangeRate":0.011102},{"month":7,"riseRate":0.666667,"avgChangeRate":0.009468},{"month":8,"riseRate":0.666667,"avgChangeRate":0.011194},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.002421},{"month":10,"riseRate":0.666667,"avgChangeRate":0.00649},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.002162},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.003597}],"exchange":"NYSE","name":"Prospect Capital Corp","nameEN":"Prospect Capital Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Prospect Capital Corp(PBC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Prospect Capital Corp(PBC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Prospect Capital Corp,PBC,Prospect Capital Corp股票,Prospect Capital Corp股票老虎,Prospect Capital Corp股票老虎国际,Prospect Capital Corp行情,Prospect Capital Corp股票行情,Prospect Capital Corp股价,Prospect Capital Corp股市,Prospect Capital Corp股票价格,Prospect Capital Corp股票交易,Prospect Capital Corp股票购买,Prospect Capital Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Prospect Capital Corp(PBC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Prospect Capital Corp(PBC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}